About Us

TargetedOnc.com provides the latest news and insight focused on next generation therapeutics and their molecular targets for practicing oncologists. As the field of oncology continues to trend toward systemic biology and molecular aberrations, the challenge facing many oncologists is staying recent and up-to-date with the future of cancer therapeutics. As such, TargetedOnc strives to provide the latest information on breaking news and updates on the burgeoning field. TargetedOnc focuses on the next stage of cancer development, focusing on cutting edge therapies and their biological targets. Content is organized by tumor type, news, and conference coverage.
Andrew J. Roth, Web Editor at TargetedOnc, received a master's degree in journalism from the University of Illinois at Urbana-Champaign and a bachelor's degree in journalism from Lehigh University.
Connect with Andrew

Sandra Kear, Managing Editor at TargetedOnc, graduated with a master's degree in English and a bachelor's degree in journalism from Southern Connecticut State University.
Connect with Sandra

Silas Inman, Director of Editorial and Multimedia, graduated with a bachelor's degree from Eastern Michigan University.
Connect with Silas

Christina Izzo, Assistant Web Editor, received a bachelor's degree in philosophy and art from Washington College.
Connect with Christina
JTT Articles
NCCN Guidelines Include Obinutuzumab in CLL
Dacomitinib Shows Responses in Subset of Head and Neck Cancer
External Resources

AJMC
HCPLive
OncLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Internal Resources

Articles
Fellows
Publications
Targeted Communications
Resources
Connect With Us:

About Us
Advertise
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright TargetedOnc 2013
Intellisphere, LLC. All Rights Reserved.